Article info
Biomarkers and heart disease
Original article
Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease
- Correspondence to Professor Dr Hermann Brenner, Division of Clinical Epidemiology and Ageing Research C070, German Cancer Research Center, POB 10 19 49, D-69009 Heidelberg, Germany; h.brenner{at}dkfz.de
Citation
Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease
Publication history
- Accepted April 9, 2011
- First published May 17, 2011.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.